Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd

02566

Company Profile

  • Business description

    Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd is a biopharmaceutical company in China. It is engaged in the research & development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on four large and fast-growing therapeutic areas: orthopedics, metabolic diseases, oncology, and hematology. Centered around these therapeutic areas, it has built a diversified product portfolio comprising several marketed products, such as Jilifen, Jijufen, Jiouting, Yinuojia, Guyoudao, etc., and has several product candidates under development, such as JY54, JY23, JY47, JY56, JY29-2, etc., targeting various indications. Geographically, the company generates maximum revenue from the Chinese Mainland, and the rest from other countries.

  • Contact

    No. 23, Eighth Street, Baiyang Street
    Qiantang District
    Zhejiang Province
    Hangzhou
    CHN

    T: +86 57186910099

    https://www.china-gene.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    1,794

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,417.6019.80-0.21%
CAC 408,714.9315.220.17%
DAX 4026,319.45179.320.69%
Dow JONES (US)54,036.93151.830.28%
FTSE 10010,901.0933.200.31%
HKSE25,830.08162.050.63%
NASDAQ26,690.62342.261.30%
Nikkei 22566,862.521,255.811.91%
NZX 50 Index13,844.1720.040.14%
S&P 5007,757.6447.680.62%
S&P/ASX 2009,228.6021.00-0.23%
SSE Composite Index3,947.917.870.20%

Market Movers